rs34353044
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_020944.3(GBA2):c.1037C>T(p.Thr346Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00103 in 1,613,142 control chromosomes in the GnomAD database, including 13 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_020944.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GBA2 | NM_020944.3 | c.1037C>T | p.Thr346Met | missense_variant | 6/17 | ENST00000378103.7 | NP_065995.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GBA2 | ENST00000378103.7 | c.1037C>T | p.Thr346Met | missense_variant | 6/17 | 1 | NM_020944.3 | ENSP00000367343.3 | ||
GBA2 | ENST00000378094.4 | c.1037C>T | p.Thr346Met | missense_variant | 6/17 | 1 | ENSP00000367334.4 | |||
GBA2 | ENST00000467252.5 | n.609C>T | non_coding_transcript_exon_variant | 3/13 | 1 |
Frequencies
GnomAD3 genomes AF: 0.00557 AC: 847AN: 152158Hom.: 7 Cov.: 32
GnomAD3 exomes AF: 0.00131 AC: 328AN: 251160Hom.: 2 AF XY: 0.000936 AC XY: 127AN XY: 135720
GnomAD4 exome AF: 0.000558 AC: 815AN: 1460866Hom.: 6 Cov.: 30 AF XY: 0.000487 AC XY: 354AN XY: 726810
GnomAD4 genome AF: 0.00559 AC: 851AN: 152276Hom.: 7 Cov.: 32 AF XY: 0.00502 AC XY: 374AN XY: 74468
ClinVar
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Dec 31, 2018 | - - |
Spastic paraplegia Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 22, 2024 | - - |
GBA2-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 14, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Hereditary spastic paraplegia Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Genome Diagnostics Laboratory, The Hospital for Sick Children | Nov 02, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at